Friday, October 2, 2026
ExploreSearch
Finance Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· March 6, 2026

Stock market today: Dow, S&P 500, Nasdaq sink after jobs report surprise as oil jumps

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq sink after jobs report surprise as oil jumps US stocks tumbled on Friday as the key monthly jobs report surprised to the downside and oil prices jumped amid fresh fears about a hit to supply from the expanding Middle East conflict…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Oil prices could surge to $150 a barrel

    80% confidence

  • Waiting for another 10% drop to Make Tech Value Again

    80% confidence

  • Increased adoption of AI tools by enterprise clients is driving demand for custom chips that power data centers

    80% confidence

  • The US will issue a waiver allowing India to buy Russian oil stranded at sea

    80% confidence

  • All Gulf energy exporters would shut down production within days

    80% confidence

  • The war on Iran would force Gulf exporters to shut off production within days

    80% confidence

  • The conflict in the Middle East could bring down the economies of the world

    80% confidence

  • The turnaround in healthcare jobs is attributed to a large labor strike at Kaiser Permanente in February

    80% confidence

  • The only path to resolution in Iran is unconditional surrender

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com